13Mar 2025
FESS and Mepolizumab Combination Enhances CRSwNP Treatment Outcomes

FESS and Mepolizumab Combination Enhances CRSwNP Treatment Outcomes

The study investigates the combined effect of functional endoscopic sinus surgery (FESS) and mepolizumab versus mepolizumab alone in treating severe chronic rhinosinusitis with nasal polyps (CRSwNP). After 6 months, both groups showed improvements in SNOT-22 scores. However, patients with larger nasal polyp scores (6-8) had significantly greater improvements in SNOT-22, nasal polyp scores (NPS), and nasal congestion with the combination therapy.

  • #ent

Like

Save

Share